- Your Internal Signal to Stop Eating is More Complex Than Previously Thought
- FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order
- Why Cardiac Monitoring Belongs at the Foundation of Your Service Line Strategy: A Conversation with Amanda Maples, RN, BSN, MHA
- Baptist Health Floyd taps chief medical officer from Asante
- Journey to joy: Leveraging national burnout data — executive insights and innovations from leading health systems
- Washington provider cuts cancellations to 19% with scheduling model
- Increasing home care capabilities to decrease hospitalizations
- ‘We want to be known as your best partner’: UnitedHealthcare leaders talk provider tensions, prior auth cuts
- Cohen Veterans Network opens 1st Kansas mental health clinic
- Mississippi treatment center sees 35% rise in alcohol admissions
- St. Jude CFO to step down for West Virginia role
- FDA backs 3 psychedelic drug studies for mental illness
- FDA backs 3 psychedelic drug studies for mental illness
- Providence launches 12 Epic AI tools
- Staffing legislation, Medicaid and more: 4 dentistry updates in Maine
- Wisconsin hospital president to retire after 51-year career
- HCA still expects up to $900M hit from ACA headwinds
- Vitana Pediatric & Orthodontic Partners adds New York practice
- Parkview Health to open outpatient facility
- 3 rising cardiovascular leaders to know
- The best ASCs for colonoscopy, endoscopy in the Northeast: US News
- How dental M&A is evolving in 2026
- Missouri physician indicted for healthcare fraud, illegal prescriptions
- The dental developments keeping leaders up at night
- Spine group to open new ASC
- States look to enhance Medicaid dental programs: 4 notes
- Weill Cornell study points to new IBD treatment strategy
- Alabama hospital to expand outpatient services
- Inpatient vs. outpatient spine surgery: What do patients prefer?
- Trump administration to change coverage for breakthrough cardiology devices
- Dr. Eugene Braunwald, the ‘father of modern cardiology,’ dies at 96
- 3 dental companies laying off employees
- 4 DSOs making headlines
- Green Lighting Capital Formation: Remarks at the SEC International Institute on Capital Formation
- Lawmakers introduce bipartisan legislation to improve access, quality of care in Medicare Advantage plans
- HCA Healthcare executives shrug off Q1 volumes disruptions, reaffirm FY2026 guidance
- Former Tobacco Executive Takes CDC Role
- New Plan Could Speed Medicare Coverage for Innovative Devices
- Heated Socks Sold at Costco Recalled After Burn Reports
- First Measles Case of the Year Reported in New Jersey
- CMS, FDA Announce RAPID Coverage Pathway to Accelerate Device Reimbursement
- CMS, FDA Announce RAPID Coverage Pathway to Accelerate Device Reimbursement
- UnitedHealthcare, Aetna, Cigna tout progress to standardize prior authorization as part of industry-wide commitment
- Sanofi gains long-awaited win for tolebrutinib as EU regulator endorses MS drug for approval
- FDA snubs AbbVie's prospective Botox heir amid series of manufacturing-related CRLs
- Industry Voices—Hospitals are very online, but what happens when they're plunged into 'digital darkness'?
- Travere’s launchpad positions Filspari for fast rise toward blockbuster sales: analyst
- Does Motherhood Shield You From Stroke?
- These Fun Pursuits Help Middle-Aged Folks Protect Brain Health, Study Finds
- New Guidelines Highlight Behavioral Therapy For Insomnia
- Playing Pretend Provides Unexpected Benefits For Growing Kids
- New Survey Estimates 8 Million Americans Used Psilocybin in 2024
- Eye Photos Might Offer Early Warning Of Chronic Health Problems, AI Study Finds
- Daiichi pushes back annual report, citing reviews amid ‘rapidly changing business conditions’
- Genentech wants ‘All Eyes on DME’ as it taps Damon Wayans for humor-laced campaign
- Pfizer's cost-cutting push reaches Ireland again as it plans manufacturing layoffs
- Fierce Pharma Asia—Merck’s PD-1xVEGF data; Zai Lab’s global view; Kailera’s record IPO
- Patients less confident than ever about health choices: survey
- Pfizer drafts Fernando Mendoza as new face of its ‘game of inches’ cancer campaign
- Avalyn aims for $182M IPO to fund phase 3 trials of reformulated respiratory drugs
- Acadia taps interim CFO amid finance chief’s departure
- Connecticut fines 5 insurers over alleged mental health parity violations
- The legislation that could change dentistry’s trajectory
- How dental AI is addressing 3 of dentistry’s most pressing issues
- Dental technology company secures $22M investment
- Meadows Behavioral Health center rebrands, expands services
- Justice Department reclassifies marijuana products: What it means for healthcare
- AI-powered prior authorizations for Medicare have greatly delayed care, Washington state hospitals say
- Can Trump’s deal with the UK become a model for similar drug price agreements?
- Cincinnati Children’s appoints psychiatry division director
- Northwell Health unveils toolkit for gun violence prevention in healthcare settings
- FTC files suit over telemarketing scheme selling fake PPO insurance
- What is psilocybin? Inside Trump’s push for psychedelic treatments
- Regeneron ushers in new genetic medicine era with groundbreaking gene therapy approval
- Molina strikes 'prudent' tone on 2026 outlook amid positive signs on Medicaid spending
- Regeneron unveils latest 'most favored nation' drug pricing deal with White House
- 988 Hotline Leads to Fewer Suicides Among Young People, Study Finds
- Drop in NIH Funding Delays Thousands of Studies
- U.K. Plans To Ban Cigarette Sales for Future Generations
- Despite data concerns, Roche’s oral SERD can still be largest product in company history: exec
- UPDATED: Roche Q1 earnings suffer from currency headwinds with hits and misses across the board
- FDA citizen petition calls on agency to tighten up CRL disclosure practices
- With Dupixent driving growth, Sanofi touts 'vigorous defense' to extend US exclusivity
- Telehealth provider Him & Hers adds all FDA-approved GLP-1s to platform
- CMS, FDA announce new program to speed up Medicare coverage of breakthrough medical devices
- With trial win, Novo Nordisk eyes adolescent diabetes approval for oral semaglutide
- Website Helps Dementia Patients And Caregivers Bond, Reminisce
- Gene Cure For Inherited Deafness Effective, Long Lasting, Clinical Trial Finds
- New Treatment, Dato-DXd, Improves Survival for Aggressive Breast Cancer
- ER Study Finds Major Gaps in Measles Immunity
- Most Americans Worried About Brain Health, But Few Know How To Protect It
- IVF 'Add On' Procedure With Hormone Human Chorionic Gonadotropin (hCG) Doesn't Work, Evidence Review Concludes
- More than 60% of Americans using AI tools for medical information: survey
- Evonik to pump €80M into Slovakia production facility, add 50 jobs
- OpenAI launches ChatGPT for Clinicians, a free AI tool for physicians, NPs and pharmacists
- Deerfield trots into pharma sales software space with CRM-enhancing tool
- Merck’s new AI commercial strategy ‘reimagining engagement with HCPs’
- Opening Remarks at the 32nd Annual International Institute for Securities Market Growth and Development
- Conservative think tank Paragon Health calls its shots on hospital policy reform
- Amazon One Medical launches GLP-1 program integrated with primary care
- CDC Report on COVID Vaccine Blocked From Publication
- Moderna Starts Large Bird Flu Study Despite Earlier HHS Funding Loss
- RFK Jr. continues congressional hearing appearances to talk White House budget plan
- RFK Jr. Won't Commit to CDC Nominee's Vaccine Decisions
- Pentagon Drops Flu Vaccine Requirement For U.S. Military
- AbbVie to establish NC production base with $1.4B investment, creating 730-plus jobs
- Zocdoc partners with Yelp to allow real-time scheduling
- CMS delays Part D GLP-1 model amid skepticism from insurers
- CMS delays Part D GLP-1 model amid skepticism from insurers
- Healthcare finance leaders cite federal funding uncertainty, Medicaid cuts as top concerns
- Bullying, Politics Harm Mental Health Of Gender-Diverse Teens
- Male Infertility Linked To Cancer Risk
- Video Game Training Sharpens ER Doctors’ Split-Second Decisions
- Hidden Belly Fat Linked to Bladder Control in Women
- Mind-Controlled Bionic Suit Lets Paralyzed Patients Feel Every Step
- Napping Linked To Higher Risk Of Death Among Seniors, Study Finds
- Oak HC/FT backs Courier Health's $50M series B to build out AI for the biopharma patient experience
- Elevance Health seeing shift to bronze tier in ACA plans
- Community Health Systems attributes Q1 volumes stumble to consumers' macroeconomic fears, payers' prior auth denials
- Children’s Activity Cubes Recalled Over Choking Hazard Risk
- 'Don't be a wimp,' Mark Cuban tells lawmakers hesitant to break up PBMs
- Study Finds AI Chatbots Can Give Misleading Health Advice
- Former Surgeon General Backs CDC Nominee, But Questions Remain on Vaccines
- Cantaloupes Recalled in Four States Due to Salmonella Risk
- Keynote Remarks at The Economic Club of Washington
- The Oral GLP-1 Tracker: Lilly's launch of Foundayo lags, boosting Novo's shares
- Service Dogs Perform Tasks Akin To Human Caregivers, Researchers Say
- A Third Of Young Adults Are Couch Potatoes, Their Parents Say
- Powerful Antibiotic Combo Not Necessary For Simple Sinus Infections, Study Shows
- Black Women Hit Hardest By Pandemic-Related Rise In Pregnancy-Related Deaths
- Smoking, Vaping Weed Increases Risk Of Asthma Attacks Among Young Adults, Study Finds
- Statement on the Amendments to Form PF
- Update on the SEC’s Work Toward Treasury Clearing Implementation
- Amperos Health secures $16M in series A funding, unveils AI-native denial management solution
- “PF” Stands for Please Fix: Statement on the Proposed Amendments to Form PF
- Beyond Reporting: Realizing Continuous Safety Surveillance for Medical Devices
- Beyond Reporting: Realizing Continuous Safety Surveillance for Medical Devices
- Safeguarding Scientific Publishing from AI Hallucinations and Fabricated Citations
- Safeguarding Scientific Publishing from AI Hallucinations and Fabricated Citations
- Why UnitedHealth Group is betting big on doulas
- Styker Adds IVL Technology to Peripheral Vascular Portfolio with Amplitude Acquisition
- Styker Adds IVL Technology to Peripheral Vascular Portfolio with Amplitude Acquisition
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- Remarks at the Options Market Structure Roundtable
- Cattywampus: Statement on the CAT Concept Release
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
This month we have dueling op-eds in the Detroit Free Press from Tricia Keith, the new President and CEO of Blue Cross/Blue Shield of Michigan followed by a response from Brian Peters, the CEO of the Michigan Health & Hospital Association.
First, Ms. Keith's opening shot on October 13th:
BCBSM CEO pens op-ed: Health care costs are rising. We need to reform the system.
Opinion by Tricia Keith - October 13, 2025The affordability of health insurance is severely strained right now, with premium increases in the double digits being passed along to many Michiganders for the past several years in a row.
Tackling this affordability crisis isn’t something we can do alone. It requires partnerships — across health systems, providers, insurers, regulators and pharmaceutical companies — to address the root causes of rising costs.
Rising health care costs hurt everyone
Skyrocketing medical and drug costs drove Blue Cross Blue Shield of Michigan’s claims expense higher by $12 million per day in 2024.
According to a recent survey from the Small Business Association of Michigan, the impact of rising premiums is now causing employers to shift more costs to their employees and to reevaluate the richness of their benefit plans, or even whether to provide coverage at all.
In Michigan, a state with such a strong tradition of employer-sponsored health insurance, we need to recognize the factors driving these costs higher and work together on system-wide solutions to keep high-quality health insurance affordable for our members.
It’s important to note that rising upstream costs for medical care, hospital care and new, expensive drugs are not just being felt downstream by health insurers — but also by employers who self-fund their health plans and the members who pay into them.
These employers assume the financial responsibility for paying a significant portion of their employees’ medical and pharmacy costs. Many of the largest Michigan companies fall into this category. The more they spend on health care, the less they spend to hire the workers, invest in the new products, and drive the growth that keeps Michigan’s economy strong.
Value-based payments
At Blue Cross Blue Shield of Michigan, 47 cents of every premium dollar was paid for hospital care in 2024. Insurers and hospital systems must partner more strongly to put more of that money to work paying for patient health — with a growing share of payment tied to the success of hospitals in achieving quality patient outcomes. The solution is leaning into the value-based payment model, and away from the antiquated “fee-for-service” where providers get paid for every test, treatment or procedure they perform — whether it helps the patient during their first visit or not.
Value-based payment models incentivize coordinated care between doctors and health systems and emphasize keeping patients healthy, reducing the need for expensive follow-up treatment.
We can’t just pay hospitals more for the same level of quality and care. We need to pay them to achieve better results.
This approach is at the heart of the multi-year payment contract Blue Cross signed earlier this year with Corewell Health. This five-year deal strives to improve the quality and affordability of patient care through multiple health outcomes-based initiatives.
We also must address — on a national level — the skyrocketing cost of prescription and specialty drugs for complex, chronic conditions and the enormous advantages provided to drug makers in pricing and marketing their expensive, but often life-changing, products.
Rising drug costs
Blue Cross’ claims expense for drugs grew 15% in 2024 — five times the rate of inflation.
The cause? Drug makers can price their products with no regulation, and enjoy patent protections that keep lower-cost competitors out of the market. This is a government-sanctioned monopoly and must be reformed to encourage competition that lowers costs.
For example, Blue Cross is investing in biosimilar drugs to provide lower-cost, effective alternatives to brand name medications. Biosimilars are interchangeable, FDA approved drugs with the same clinical effectiveness as their brand name counterpart. Our switch to a biosimilar for the autoimmune and inflammatory disease drug Humira resulted in saving our customers over 90% of the list price of that medication. We need more competition like this because it lowers costs.
The high cost of advertising
As we all know well, there is also drug advertising. In just the first three months of this year, drug makers spent $729 million on television advertising to drive demand for their high-priced products. In 2024, they spent $5.3 billion on television ads. And it’s all tax-deductible.
Recently, the current administration announced a proposal to rein in TV advertising for prescription drugs. Why does this matter? Direct-to-consumer advertising for prescription drugs increases patient demand, which raises the ability of manufacturers to negotiate higher prices for already expensive drugs. Meaning these higher costs impact individuals and businesses downstream.
The Blue Cross and Blue Shield Association supports a proposal to eliminate the tax deductibility of pharmaceutical advertising, saving $137 billion from 2026-2035. The bottom line is, we need to reform this system that drives drug prices — and health insurance premiums — higher.
These are among many initiatives that Blue Cross supports to help our members, customers and economy better afford health care. Affordability matters. But we need more system-wide solutions to curtail escalating costs and keep health insurance within reach for businesses and people ― and we have to work together to reach them.
Tricia Keith is the new (this year) president and CEO of Blue Cross Blue Shield of Michigan.
Here is Brian Peter's response:
Hospital association head: 'Finger-pointing' won't fix rising health care costs | Opinion
By Brian Peters, Op-ed contributor - October 21, 2025Finger-pointing makes headlines, but it won’t fix Michigan’s health care challenges. Rising costs are real for families and employers — and for hospitals, too. What’s not real is the claim that hospitals are driving those costs with unnecessary or ineffective care. That narrative misunderstands the complexities pushing spending higher, and risks harming patients by undermining the very providers keeping emergency rooms, trauma centers and maternity units open.
Let’s start with what hospitals can’t control.
Drug spending surged in 2024, driven by several high-cost medicines in oncology, diabetes and autoimmune disease, the PwC Health Research Institute found. At the same time, labor — the people who staff intensive care units, operating rooms and emergency departments around the clock — is the single largest expense for hospitals, accounting for more than half of total costs as wages rose to retain nurses and other critical staff during an unprecedented workforce shortage, according to the American Hospital Association.
On top of that, inflation, supply chain disruptions and tariffs continue to push up the price of routine medical supplies, from surgical gowns to IV tubing.
Reimbursements don't cover the cost of care
Hospitals also treat everyone seeking emergency care. In line with our mission and federal law, we care for everyone who comes through our doors, 24/7, regardless of their ability to pay. When a patient arrives with a stroke at 3 a.m. or a child needs trauma care after a car crash, no hospital in Michigan asks for a credit card before providing care. That’s a promise we will always keep.
Meanwhile, public reimbursements routinely fail to cover the cost of that care. In the most recent national data, Medicare paid just about 83 cents for every dollar it costs hospitals to care for a Medicare patient, contributing to more than $130 billion in annual underpayments when Medicare and Medicaid are combined, per the American Hospital Association. Hospitals also deliver tens of billions of dollars in essential but uncompensated care each year to patients with no ability to pay, the association found.
Michigan’s picture mirrors these national pressures. Hospitals across our state continue to absorb more than $1 billion in uncompensated and under-reimbursed care collectively. Rural and northern communities feel these pressures most acutely, where keeping obstetrics or inpatient psychiatric services open can hinge on razor-thin margins, the Michigan Health & Hospital Association, the group I lead, found.
Follow the money
Margins tell the real story.
Michigan was one of only four states in the country where hospitals had, on average, a negative margin, according to the Kaiser Family Foundation. In rural America, closures and conversions have accelerated since 2010, and nearly half of rural hospitals nationally are now in the red, and hundreds vulnerable to closure.
In Michigan, more than half of rural hospitals are operating at negative margins, the Chartis Center for Rural Health reported. These are not signs of a system profiteering off patients. These are signals of a system under financial stress.
And when hospitals are financially destabilized, patients pay the price, not through higher prices but through lost access. When a mother in the U.P. must drive over an hour to deliver a baby, that’s not a finance story. It’s a public safety crisis.
If you want to know who is profiteering off health care, follow the money.
Independent analyses show drug manufacturers’ margins far exceed those of hospitals, with drug company profitability running two to three times higher than hospital margins in many comparisons, according to the Journal of the American Medical Association (JAMA). A 2024 review of sector margins likewise found that PhRMA’s average net income margins dwarf those of other drug-supply-chain players, the Campaign for Sustainable Rx Pricing found.
Hospitals are the backbone of care
Hospitals are doing our part.
Across Michigan, hospitals are moving care to more affordable settings, using lower-cost medication alternatives when appropriate, improving care coordination and expanding the behavioral health workforce.
But no health system can sustain 24/7 readiness — trauma, neonatal intensive care, emergency psychiatry — if reimbursement chronically fails to meet the actual cost of care and costs for labor, supplies and drugs continue to rise.Let’s be honest with patients and employers: Hospitals are not the villains of affordability.
We’re the backbone of access: the nurse at the bedside at 3 a.m., the surgical team on call, the therapist helping a child walk again. Michigan hospital teams will keep showing up with compassion and professionalism.
What we ask in return is an honest conversation grounded in facts, not talking points, because protecting access to care in every Michigan community is a responsibility we all share.
Brian Peters is CEO of the Michigan Health & Hospital Association. It should be noted that Republican House Speaker Matt Hall has called for his ouster, repeatedly, after President Peters and his group criticized the nearly $79 billion Michigan FY 26 budget. President Peters is quite enthusiastic about health care spending.
Stephen Rapundalo, the President and CEO of Ann Arbor-based MichBio, the Michigan Biosciences Industry Association, wants in on the debate:
BCBSM CEO blamed drug industry for rising health care costs. She got it wrong. | Letter
By Stephen Rapundalo - October 23, 2025In a recent ep-ed, Blue Cross and Blue Shield of Michigan CEO Tricia Keith laid out a number of cost drivers in the health care system.
Unfortunately, she didn’t take any responsibility for the role that Blue Cross plays in the increased costs to patients. Instead, she assigned blame to other players in the system, without proposing what health insurers could actually do to help reduce costs.
BCBSM CEO pens op-ed: Health care costs are rising. We need to reform the system.
I lead the Michigan Biosciences Industry Association, or MichBio, an association of research and manufacturer companies that develop life-improving and life-saving medicines for patients in need.Michigan has been on the leading edge of some of the most blockbuster drugs that continue to help people live better and longer lives.
Just two examples include Lipitor, the best-selling cholesterol-lowering drug in history, which was developed in Ann Arbor at Parke-Davis Pharmaceuticals, and AZT, the first approved treatment for HIV/AIDS, discovered at Wayne State University, giving hope to millions across the globe.
The fact is, medical science has never been more promising, and despite all the groundbreaking innovation in medicine, spending on medicines remains a small and stable 14% of total health spending.
I was especially surprised that Keith didn’t mention the role that Pharmacy Benefit Managers (PBMs) play in inflating the costs of prescriptions for patients. They’re the middlemen that set the actual price of medications. Pharmaceutical companies sell their products at much lower costs, but PBMs mark up the price and make billions in profits as a result. Some PBMs are owned by the actual pharmacies, so they’re making huge profits off every step in the health care process.
Instead, Keith proposed eliminating the ability of pharmaceutical companies to advertise their products. The result would be a less informed patient, and lead to insurance company bean counters telling your doctor what they can and cannot prescribe. This would not make health care better; it would make bigger profits for health insurers.
If Keith wants to go down the advertising route, Blue Cross should consider reducing its advertising and sponsorship budget. You can’t attend a sporting event without seeing their logo plastered all over the stadium.
What if they, instead, reduced their costs to patients with those funds? Maybe they wouldn’t have to charge double-digit premium increases every year.
Keith also complains about patent protection for companies that have made major discoveries. Can you imagine investing billions into research and development to come up with a life-saving medicine, you file for a patent and are told it’s only valid for seven years?
In fact, 90% of prescriptions in the U.S. are filled with lower-cost generics and biosimilars.
As a company, you have to cover your investment costs within that timeframe, and then generics manufacturers are allowed to make and sell your product. Seven years is a very short timeline, but without even that minimal protection, who would do the research and testing that’s necessary?
The bottom line is that everyone in the health care ecosystem has a role to play in reducing costs for patients.
So instead of pointing fingers, how about if everyone sits down and figures out what is best for patients?
That may be the optimist in me hoping for that kind of result, but it’s the only way we’re going to do what’s right by the patients that the system is supposed to help.
The Hill brings the bigger picture of public perspective.
Chronic finger-pointing can be entertaining, but have you noticed that for industry it's all about managing people's lives?
What gets really interesting is personal responsibility, medical debt, and individual freedom.
https://thehill.com/policy/healthcare/5572504-healthcare-affordability-voter-poll/
Many voters say health care unaffordable, are open to new insurance system: Poll
Joseph Choi | 10/27/25
New polling has found that the majority of voters say health care in the U.S. is unaffordable and are open to a health insurance system that doesn’t tie coverage to employment.
Undue Medical Debt, a nonprofit that works to eliminate medical debt and supports policies to prevent new debt, sponsored the poll, which was led by the nonpartisan research firm PerryUndem. Along with a national survey, focus groups were also asked for their opinions on health care.
The poll was provided first to The Hill.
The survey found that 69 percent of voters believe that health care is not affordable today, with that figure remaining relatively consistent across parties.
Thirty-five percent of participants said they currently owed money or have debt due to medical or dental expenses. The same percentage said they had skipped or delayed medical care in the last year due to fears of medical debt.
Survey participants were asked whether they made at least one of eight material sacrifices in the past year in order to meet their financial goals. These included eating less food, skipping vacations, putting more of their expenses on credit cards, falling behind on bills and borrowing money from friends and family.
Among those surveyed, 68 percent said they had engaged in at least one of those practices, with 43 percent saying they’d eaten less or bought less expensive, less healthy foods.
One participant, a 43-year-old uninsured white woman in West Virginia, said in the survey, “I go to a food pantry and I work three jobs. You know what I mean? It’s hard, and it shouldn’t be that hard. I don’t have time to spend with my kids. I don’t have time to do things, because I have to work to eat, you know, and that’s what makes it hard for me.”
“This is a common ground issue that you know is resonating with people. Health care is clearly unaffordable,” Allison Sesso, president and CEO of Undue Medical Debt, told The Hill.
“What I thought was really interesting is really the focus on insurance,” Sesso added. “Seventy-four percent saying that insurance is failing to protect them from medical debt. And I think that that, to me, is a little bit new. Not that it’s new that insurance isn’t working that great, but that such a large percentage of voters on both sides of the aisle were pointing that out as one of the biggest failures.”
Sixty-three percent of participants said they blamed insurance companies the most for medical debt, which was very distantly followed by pharmaceutical companies at 12 percent and hospitals at 9 percent.
Seventy-six percent of voters said they agreed with the statement: “We need to switch to a different system of health insurance where people can change jobs or become self-employed and not have to worry about losing their health insurance.”
“They want to see a system that doesn’t tie them so tightly to their jobs, because it prevents them from moving around,” Sesso said. “And, you know, if you’re not sick, you’re sort of punished to stay at the job, and you don’t have the ability to be sort of self-employed, that you have to sort of hold on to that job for the insurance aspect of it
When it came to addressing medical debt, 76 percent said they wanted their states to pass laws shielding them from medical debt. Measures that received significant support included limiting the interest rate allowed on medical debt, limiting the ability of collection agencies to take a person’s belongings due to medical debt and requiring hospitals to use the same user-friendly application for financial assistance.
Eighty-one percent said they supported the creation of a state-funded health plan that would give residents a more affordable option than commercial plans.
Seventy-seven percent of voters said they would feel more positive about state elected officials if they passed laws with these measures and 75 percent said they would be more likely to vote for someone if they passed these laws.
The ongoing discourse over health insurance and ensuring people can afford it is what is currently keeping the federal government shut down. The current shutdown is already the second-longest in U.S. history, and Democrats are refusing to budge unless a deal is struck to extend enhanced premium tax credits for Affordable Care Act Marketplace plans.
“I’m not surprised that health care is at the center of this conversation. Medical debt and healthcare affordability are, you know, among the few issues where Americans actually agree at this moment,” Sesso said. “I think they’re not holding their breath for Washington to act and to protect them necessarily from medical debt, which is why I think they’re, you know, looking for states to take action.”
For the survey, 1,319 voters in the 2024 general election were included in a 12-minute national survey. The survey was conducted from Aug. 21 to Sept. 2. The results have a margin of error of 3.63 percentage points.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.






